Leveraging Structured Biological Knowledge for Counterfactual Inference: A Case Study of Viral Pathogenesis.
Jeremy D ZuckerKaushal PaneriSara Mohammad-TaheriSomya BhargavaPallavi KolambkarCraig BakkerJeremy TeutonCharles Tapley HoytKristie L OxfordRobert NessOlga VitekPublished in: IEEE transactions on big data (2021)
Counterfactual inference is a useful tool for comparing outcomes of interventions on complex systems. It requires us to represent the system in form of a structural causal model, complete with a causal diagram, probabilistic assumptions on exogenous variables, and functional assignments. Specifying such models can be extremely difficult in practice. The process requires substantial domain expertise, and does not scale easily to large systems, multiple systems, or novel system modifications. At the same time, many application domains, such as molecular biology, are rich in structured causal knowledge that is qualitative in nature. This article proposes a general approach for querying a causal biological knowledge graph, and converting the qualitative result into a quantitative structural causal model that can learn from data to answer the question. We demonstrate the feasibility, accuracy and versatility of this approach using two case studies in systems biology. The first demonstrates the appropriateness of the underlying assumptions and the accuracy of the results. The second demonstrates the versatility of the approach by querying a knowledge base for the molecular determinants of a severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)-induced cytokine storm, and performing counterfactual inference to estimate the causal effect of medical countermeasures for severely ill patients.
Keyphrases
- sars cov
- healthcare
- respiratory syndrome coronavirus
- single cell
- end stage renal disease
- systematic review
- ejection fraction
- chronic kidney disease
- coronavirus disease
- newly diagnosed
- type diabetes
- high resolution
- physical activity
- adipose tissue
- high glucose
- insulin resistance
- patient reported outcomes
- endothelial cells
- big data
- mass spectrometry